Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

217 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Coronary risk factors and plasma sex hormones.
Lindholm J, Winkel P, Brodthagen U, Gyntelberg F. Lindholm J, et al. Among authors: winkel p. Am J Med. 1982 Nov;73(5):648-51. doi: 10.1016/0002-9343(82)90405-3. Am J Med. 1982. PMID: 6890309
Plasma sex hormones and ischemic heart disease.
Eldrup E, Lindholm J, Winkel P. Eldrup E, et al. Among authors: winkel p. Clin Biochem. 1987 Apr;20(2):105-12. doi: 10.1016/s0009-9120(87)80108-x. Clin Biochem. 1987. PMID: 3301063 Review.
Health effects of toluene exposure.
Mørck HI, Winkel P, Gyntelberg F. Mørck HI, et al. Among authors: winkel p. Dan Med Bull. 1988 Apr;35(2):196-200. Dan Med Bull. 1988. PMID: 3359818
High serum YKL-40 concentration is associated with cardiovascular and all-cause mortality in patients with stable coronary artery disease.
Kastrup J, Johansen JS, Winkel P, Hansen JF, Hildebrandt P, Jensen GB, Jespersen CM, Kjøller E, Kolmos HJ, Lind I, Nielsen H, Gluud C; CLARICOR Trial Group. Kastrup J, et al. Among authors: winkel p. Eur Heart J. 2009 May;30(9):1066-72. doi: 10.1093/eurheartj/ehp049. Epub 2009 Mar 6. Eur Heart J. 2009. PMID: 19270316 Free article. Clinical Trial.
High-sensitivity C-reactive protein and N-terminal pro-B-type natriuretic peptide in patients with stable coronary artery disease: a prognostic study within the CLARICOR trial.
Harutyunyan MJ, Mathiasen AB, Winkel P, Gøtze JP, Hansen JF, Hildebrandt P, Jensen GB, Hilden J, Jespersen CM, Kjøller E, Kolmos HJ, Gluud C, Kastrup J; CLARICOR Trial Group. Harutyunyan MJ, et al. Among authors: winkel p. Scand J Clin Lab Invest. 2011 Feb;71(1):52-62. doi: 10.3109/00365513.2010.538081. Epub 2010 Nov 25. Scand J Clin Lab Invest. 2011. PMID: 21108561 Clinical Trial.
10-Year Associations Between Tumor Necrosis Factor Receptors 1 and 2 and Cardiovascular Events in Patients With Stable Coronary Heart Disease: A CLARICOR (Effect of Clarithromycin on Mortality and Morbidity in Patients With Ischemic Heart Disease) Trial Substudy.
Carlsson AC, Ruge T, Kjøller E, Hilden J, Kolmos HJ, Sajadieh A, Kastrup J, Jensen GB, Larsson A, Nowak C, Jakobsen JC, Winkel P, Gluud C, Ärnlöv J. Carlsson AC, et al. Among authors: winkel p. J Am Heart Assoc. 2018 Apr 23;7(9):e008299. doi: 10.1161/JAHA.117.008299. J Am Heart Assoc. 2018. PMID: 29686027 Free PMC article. Clinical Trial.
217 results